ArticlemedRxiv : the preprint server for health sciences2024

A pilot study to identify blood-based markers associated with response to treatment with Vedolizumab in patients with Inflammatory Bowel Disease.

John D Rioux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.